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A B S T R A C T
In 2002, International Agency for Research on Cancer launched a multicentric case-control study of head and neck
cancer in 15 centres in 11 European countries, Croatia included. The Alcohol-related Cancers and Genetic Susceptibility
in Europe (ARCAGE) study database with approximately 2500 case-control pairs is currently the largest head and neck
cancer patients database in Europe. The aim of the present study was to estimate the risk of smoking and alcohol con-
sumption in head and neck cancer patients from Zagreb region recruited in scope of the ARCAGE study. The cases (45
males, 9 females) and the controls (37 males, 9 females) were recruited from University Hospital Dubrava and Merkur
University Hospital. A blood sample and a lifestyle questionnaire were collected from all study subjects. Data were ana-
lysed by logistic regression analysis. The distribution of cases was: 43 oral, 9 pharyngeal and 2 laryngeal cancer cases.
Ever-smokers had a 4-fold higher cancer risk (adjusted OR 4.3 (CI 1.20–15.4)) compared to never-smokers. The adjusted
odds ratio for alcohol consumption more than once a week was 4.1 (CI 1.5–11.2). The results are in keeping with previ-
ously published data from other countries.
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Introduction
Head and neck cancer includes cancers of oral cavity,
pharynx, larynx and oesophagus. Worldwide, it is the
most common cancer in men younger than 55 years, with
the highest proportion of cases between the ages 45 and
64. The incidence is decreasing in men, while an increas-
ing trend has been observed in women1,2. There are esti-
mated 177,000 new cases of these cancers yearly in Eu-
rope, comprising 8.0% of male and 2.5% of female cancer
incidence3. In Croatia, there are 1,179 new cases yearly,
which is 8.7% of male and 1.8% of female cancer in-
cidence4. No significant improvement of survival of Eu-
ropean head and neck cancer patients has been observed
over the last 20 years5–8. Alcohol and tobacco consump-
tion are well established risk factors for head and neck
cancers9,10. Different types of DNA damage have been
shown to occur in human tissues from subjects who con-
sume alcohol; however, the relationship between oxida-
tive stress-induced DNA lesions and alcohol consump-
tion has not been well established. Ehtanol metabolite
acetaldehyde reacts with DNA to form different DNA ad-
ducts, and elevated levels of acetaldehyde-derived DNA
adducts have been detected in white blood cells of indi-
viduals who are heavy drinkers. Some of these adducts
are mutagenic in human cells10. Tobacco smoke is geno-
toxic in humans and in experimental animals. The smok-
ing-related DNA adducts are derived from various com-
pounds including aromatic amines (e.g. 4-aminobiphe-
nyl), polycyclic aromatic hydrocarbons (e.g. benzo[a]py-
rene), tobacco-specific nitrosamines (e.g. 4-(methylnitro-
samino)-1-(3-pyridyl)-1-butanone), benzene, acrylamide
and acrylonitrile9. Some polymorphisms of genes invol-
ved in alcohol metabolism (such as alcohol and aldehyde
dehidrogenases), tobacco metabolism (such as cytochro-
me P450 N-acetyl-trasnsferase and glutathione-s-trans-
ferase family), as well as DNA repair and cell cycle con-
trol genes are associated with head and neck cancer risk
and may contribute to interindividual variations in
risk11–19.
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The role of HPV infection in pathogenesis of some of
these cancers has also been established20. To address
these factors, as well as their interactions, in 2002 IARC
launched an international multicentre study »Alcohol-
-related Cancers and Genetic Susceptibility in Europe
(ARCAGE)« including 15 centres in 11 countries. The
duration of the study was between 2002 and 2005, throu-
ghout which period, data on 2347 cases and 2254 controls
were collected, and the results on both genetic and envi-
ronmental factors were published subsequently21–23. In
scope of the Croatian part of the study, data on 100 sub-
jects were collected. The aim of our study was to describe
the study population and estimate the risk of smoking
and alcohol consumption in head and neck cancer pa-
tients from Zagreb region.
Methods
Data collection
The 54 cases (45 men, 9 women) and 46 controls (37
men, 9 women) were recruited from two hospital centres,
Dubrava University Hospital and »Merkur« University
hospital in the period 2003–2005. The distribution of the
cases was 43 oral, 9 pharyngeal and 2 laryngeal cancers.
Mean ages of the cases were 54.91 (1.33) for men and
56.78 (3.07) for women. Mean ages of the controls were
59.16 (1.77) for males and 54.78 (3.70) for females. Cases
were defined as patients with a cancer of the oral cavity
(excluding parotid gland), pharynx (excluding nasophar-
ynx) and larynx, and identified from the participating
hospitals as soon as possible after diagnosis was estab-
lished and no later than six months after diagnosis. No
oesophageal cancer cases were recruited into the study.
Only patients with histologically confirmed diagnosis
were considered eligible for the study. Controls were also
recruited from the participating hospitals and frequency
matched by age and sex. All study subjects were from
Zagreb and the surrounding county. The definition of the
controls was based on admission diagnoses not related to
alcohol or tobacco consumption and dietary habits. Par-
ticipation rates were 95% for cases and 100% for controls.
A lifestyle questionnaire developed for the ARCAGE stu-
dy was collected from all subjects. The questionnaire was
administered by a trained interviewer and comprised
sections on smoking, alcohol and dietary habits, oral
health and occupational history. Blood samples of 10ml
were collected from all study subjects, and processed at
the laboratory Merkur according to the ARCAGE study
protocol21. All study subjects have signed the informed
consent form for both lifestyle interview and blood sam-
ple collection. Ethical approval for the study has been ob-
tained from both hospital centres, as well as from the
Croatian National Institute of Public Health.
Statistical analysis
The data describing study population are presented
for men and women separately, while they were collapsed
for the purpose of analysis. Since the category of ever al-
cohol consumption was very broadly defined as »at least
once a month«, for the purpose of the analysis we created
a new variable for »at least once a week« alcohol consum-
ption. Therefore some missing values were generated.
Odds ratios (OR) and 95% confidence intervals (CI)
for head and neck cancer were estimated according to
smoking and alcohol habits using unconditional multiple
logistic regression models. All ORs were adjusted for age,
center and level of education. OR corresponding to one
habit was obtained after adjusting for the other habits24.
Results
Altogether 100 subjects were recruited into the study,
54 cases and 46 controls. The distribution of cases and
controls by sex, educational level and smoking and alco-
hol habits is presented in Table 1. The distribution of ed-
ucation levels were similar in male cases and controls,
while for females, the proportion of cases with more than
8 years of education was higher than in controls. The
proportions of ever smokers were higher in cases, but
still very high in control populations. The proportion of
subjects consuming alcohol more than once a week was
higher in cases.
Table 2 presents the odds for ever smoking and drink-
ing and the risk for UADT cancer. Adjusted OR for ever
smoking was OR 4.3 (CI 1.20–15.4), while the adjusted
odds ratio for alcohol consumption more than once a
week was 4.1 (1.5–11.2). Education level was not a signif-
icant risk factor in the analysis.
Discussion
In spite of the recently established role of HPV infec-
tion in the causation of a subset of head and neck can-
cers, smoking and alcohol consumption still remain the
most important risk factors, which is of a particular im-
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TABLE 1
DISTRIBUTION OF THE CROATIAN ARCAGE STUDY SUBJECTS
BY EDUCATION, SMOKING AND DRINKING HABITS,
GENDER AND CASE/CONTROL STATUS
Cases Controls
M F M F
N % N % N % N %
Education
<8 years 15 33.3 2 22.2 13 35.4 3 33.3
>8 years 30 66.7 7 77.8 24 64.9 6 66.7
Smoking
Never 3 6.7 2 22.2 9 24.3 4 44.4
Ever 42 93.3 7 77.8 28 75.8 5 55.6
Alcohol*
<1 ´ weekly 10 23.3 1 11.1 14 50.0 4 66.7
>1 ´ weekly 33 76.7 8 88.9 14 50.0 2 33.3
*Lower number of cases and controls due to missing values
portance in areas with high prevalence of these lifestyle
habits, such as Eastern and South-East Europe9,10,20,25.
In our study population, there was a high prevalence of
smoking even among the controls, reflecting the high
prevalence of this habit in Croatia. The results of the
2003 Croatian Health Survey report the prevalence of
smoking of 33.8% in males, and 21.7% in females older
than 18 years26. In spite of the fact that the Croatian
age-standardised mortality rates of both cancer and car-
diovascular diseases are among the highest in Europe,
the smoking ban was introduced in May 2009, but was
subsequently withdrawn25,27. The 2003 Croatian Health
Survey also demonstrated high prevalence of alcohol
consumption28. According to our results, smoking and
regular alcohol consumption increased the risk of UADT
cancer more than 4-fold each, which is in keeping with
the previously published evidence9,10. Due to small num-
ber of subjects, we have not analysed the interaction be-
tween the two habits, but their synergistic effect has
been documented elswhere10.
The evidence on the association between fruit and
vegetable consumption and the reduction of UADT can-
cer risk was evaluated as »probable, but not convinc-
ing«29. The results of the ARCAGE study have shown
that the consumption of red meat, but not poultry, was
significantly associated with increased UADT cancer risk,
while the consumption of fresh non-starchy vegetables,
fruits, olive oil and tea was associated with reduced
UADT cancer risk22. Another study from central and
Eastern Europe has shown the inverse association be-
tween consumption of yellow/orange vegetables and oral,
pharyngeal and laryngeal cancer30. The Croatian part of
the ARCAGE study results showed no statistically signif-
icant differences between cases and controls in frequency
of different food items consumption. Of the seven items
analysed, the one most frequently consumed was coffee
(14 times a week for all strata), while the one most infre-
quently consumed was olive oil (ranging between 0 and
0.3 times a week). Consumption of all meat was very fre-
quent (median 5.2–6.6 times a week), while fish con-
sumption was very low (median 0.5–1 times a week). All
vegetables consumption was low, 4 times a week for all
strata except for female controls, while fruit consump-
tion was even lower, ranging between 2 and 4 times a
week22. The 2003 Croatian Health Survey has shown
that the there are large differences in dietary habits at
county and regional level. The catchment area of our
study was within Northern Croatian region, which had
significantly higher consumption of animal fats and lo-
wer consumption of fruits and vegetables than partly
Mediterranean Southern and Western regions31. The fin-
dings on frequency of different food items consumption
from our study confirm this unsatisfactory state of di-
etary habits.
In spite of the growing evidence on the role of differ-
ent metabolic polymorphisms in the carcinogenesis of
head and neck cancers17–20,24,32, the scope for prevention
still remains with modifiable risk factors. The age-stand-
ardised rates (W) of head and neck cancer incidence
(32.5/100,000 for males and 3.9/100,000 for females in
2009) in Croatia are high, and the burden of these can-
cers is still increasing4. The major part of this burden in
Croatia, as well as in the other areas could be reduced by
applying effective prevention measures.
The ARCAGE study was one of the first epidemiologi-
cal European Comission Framework 5 Programme stud-
ies with Croatian participation. Even though the number
of subjects recruited was modest due to non-applicability
of Croatia for EC funding at that time, consequently not
yielding possibilities for detailed analysis, it contributed
to the important new evidence on both environmental
and genetic risk factors for head and neck cancers ob-
tained in scope of the ARCAGE study22,23,32. In light of
newly available molecular methods such as genome-wide
association studies, multicentric case-control studies or
study consortia with a large number of subjects provide
novel opportunities for clarifying disease etiology. Conse-
quently, there is a continuing development of statistical
methodology. In Croatia, such methodologies, as well as
education for their application are only partially availa-
ble. Therefore, the participation of Croatia in interna-
tional multicentre studies is very important, both in
terms of contribution to the body of scientific evidence,
and to the Croatian science.
R E F E R E N C E S
1. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C, PAR-
KIN DM, GLOBOCAN 2008 cancer incidence, mortality and prevalence
worldwide IARC CancerBase No. 10, version 1.2 (International Agency
for Research on Cancer, Lyon, 2010.). — 2. CURADO MP, HASHIBE M,
Curr Opin Oncol, 21 (2009) 194. — 3. FERLAY J, PARKIN DM, STE-
LIAROVA-FOUCHER E, Eur J Cancer, 46 (2010), 765. — 4. CROATIAN
NATIONAL INSTITUTE OF PUBLIC HEALTH: Cancer incidence in
Croatia. Bulletin No. 34 (Croatian National Institute of Public Health,
Zagreb, 2011). — 5. BERRINO F, SANT M, VERDECCHIA A, CAPOCA-
CCIA R, HAKULINEN T, ESTEVE J, Survival of cancer patients in Eu-
rope. The EUROCARE study. IARC Scientific publications No. 132. (In-
ternational Agency for Research on Cancer, Lyon, 1995). — 6. BERRINO
F, CAPOCACCIA R, ESTEVE J, GATTA G, HAKULINEN T, MICHELI A,
SANT M, VERDECCHIA A, Survival of cancer patients in Europe: the
A. Znaor et al.: Head and Neck Cancer in Zagreb, Croatia, Coll. Antropol. 35 (2011) 4: 1125–1128
1127
TABLE 2
ODDS RATIOS FOR EVER SMOKING AND DRINKING HABITS IN
THE CROATIAN ARCAGE STUDY SUBJECTS
Controls Cases OR 95%CI OR* 95%CI
Smoking
Never 13 33 1.0 – – –
Ever 5 49 3.9 1.3–11.9 4.3 1.2–15.4
Alcohol
<1 ´ weekly 18 11 1.0 – – –
>1 ´ weekly 16 41 4.2 1.6–10.8 4.1 1.5–11.2
* OR adjusted for age, education level, sex, smoking or alcohol
consumption
EUROCARE-2 study. IARC Scientific Publications No. 151. (Internatio-
nal Agency for Research on Cancer, Lyon, 1999). — 7. SANT M, AARE-
LEID T, BERRINO F, BIELSKA LASOTA M, CARLI PM, FAIVRE J,
GROSCLAUDE P, HÉDELIN G, MATSUDA T, MØLLER H, MØLLER
T, VERDECCHIA A, CAPOCACCIA R, GATTA G, MICHELI A, SAN-
TAQUILANI M, ROAZZI P, LISI D, EUROCARE WORKING GROUP,
Ann Oncol, 14 Suppl 5 (2003) v61. — 8. SANT M, ALLEMANI C, SAN-
TAQUILANI M, KNIJN A, MARCHESI F, CAPOCACCIA R; EUROCA-
RE WORKING GROUP, Eur J Cancer, 45 (2009) 931. — 9. INTERNA-
TIONAL AGENCY FOR RESEARCH ON CANCER, Tobacco smoke
and involuntary smoking, IARC Monographs on the Evaluation of Car-
cinogenic Risk of Chemicals to Humans, Vol. 83. (International Agency
for Research on Cancer, Lyon, 2004). — 10. INTERNATIONAL AGE-
NCY FOR RESEARCH ON CANCER. Alcoholic Beverage Consumption
and Ethyl Carbamate (Urethane), Vol. 96, 6–13 February 2007, accessed
01.07.2009. Available from: URL: http: //monographs.iarc.fr/ENG/Meet-
ings/vol96-summary.pdf. — 11. SANDERSON S, SALANTI G, HIG-
GINS J, Am J Epidemiol, 166 (2007) 741. — 12. MORITA S, YANO M,
TSUJINAKA T, OGAWA A, TANIGUCHI M, KANEKO K, SHIOZAKI
H, DOKI Y, INOUE M, MONDENM, Int J Cancer, 79 (1998) 517. — 13.
OLSHAN AF, WEISSER MC, WATSON MA, BELL DA, Cancer Epide-
miol Biomarkers Prev, 9 (2000) 185. — 14. STACY A, GEISLER A, OL-
SHAN A, Am J Epidemiol, 154 (2001) 95. — 15. HASHIBE M, BREN-
NAN P, STRANGE RC, BHISEY R, CASCORBI I, LAZARUS P, OPHIU
M, BENHAMOU S, FOULKES W, KATOH T, COUTELLE C, ROMKES
M, GASPARI L, TAIOLI E, BOFFETTA P, Cancer Epidemiol Biomar-
kers Prev, 12 (2003) 1509. — 16. SUGIMURA T, KUMIMOTO H, TOH-
NAI I, FUKUI T, MATSUO K, TSURUSAKO S, MITSUDOK, UEDAM,
TAJIMA K, ISHIZAKI K, J Oral Pathol Med, 35 (2006) 11. — 17. HA-
SHIBE M, BOFFETTA P, ZARIDZE D, SHANGINA O, SZESZENIA-
-DABROWSKA N, MATES D, JANOUT V, FABIANOVA E, BENCKO V,
MOULLAN N, CHABRIER A, HUNG R, HALL J, CANZIAN F, BRE-
NNAN P, Cancer Epidemiol Biomarkers Prev, 15 (2006) 696. — 18. BRE-
NNAN P, LEWIS S, HASHIBE M, BELL DA, BOFFETTA P, BOUCHA-
RDY C, CAPORASO N, CHEN C, COUTELLE C, DIEHL SR, HAYSE
RB, OLSHAN AF, SCHWARTZ SM, STURGIS EM, WEI Q, ZAVRAS AI,
BENHAMOU S, Am J Epidemiol, 159 (2004) 1. — 19. PETERS ES, MC-
CCLEAN MD, LIU M, EISEN EA, MUELLER N, KELSEY KT, Cancer
Epidemiol Biomarkers Prev, 14 (2005) 476. — 20. INTERNATIONAL
AGENCY FOR RESEARCH ON CANCER, Human Papillomaviruses.
IARC Monographs on the Carcinogenic Risk of Chemicals to Humans
(International Agency for Research on Cancer, Lyon, 1995). — 21. LA-
GIOU P, GEORGILA C, MINAKI P, AHRENS W, POHLABELN H, BEN-
HAMOU S, BOUCHARDY C, SLAMOVA A, SCHEJBALOVA M, MER-
LETTI F, RICHIARDI L, KJAERHEIMK, AGUDOA, CASTELLSAGUE
X, MACFARLANE TV, MACFARLANE GJ, TALAMINI R, BARZAN L,
CANOVA C, SIMONATO L, LOWRY R, CONWAY DI, MCKINNEY PA,
ZNAOR A, MCCARTAN BE, HEALY C, NELIS M, METSPALU A, MAR-
RONM, HASHIBE M, BRENNAN PJ, Eur J Cancer Prev, 18 (2009) 76. —
22. LAGIOU P, TALAMINI R, SAMOLI E, LAGIOU A, AHRENS W, PO-
HLABELN H, BENHAMOU S, BOUCHARDY C, SLAMOVA A, SCHEJ-
BALOVA M, MERLETTI F, RICHIARDI L, KJAERHEIM K, AGUDO A,
CASTELLSAGUE X, MACFARLANE TV, MACFARLANE GJ, BIGGS AM,
BARZAN L, CANOVA C, SIMONATO L, LOWRY R, CONWAY DI, MC-
KINNEY PA, ZNAOR A, MCCARTAN BE, HEALY CM, MARRONM, HA-
SHIBE M, BRENNAN P, Int J Cancer, 124 (2009) 2671. — 23. CANOVA C,
HASHIBE M, SIMONATO L, NELIS M, METSPALU A, LAGIOU P, TRI-
CHOPOULOS D, AHRENS W, PIGEOT I, MERLETTI F, RICHIARDI L,
TALAMINI R, BARZAN L, MACFARLANE TV, MACFARLANE GJ, HOL-
CATOVA I, BENCKO V, BENHAMOU S, BOUCHARDY C, KJAERHEIM
K, LOWRY R, AGUDO A, CASTELLSAGUE X, CONWAY DI, MCKIN-
NEY PA, ZNAOR A, MCCARTAN BE, HEALY CM, MARRON, BRENNAN
P, Cancer Res, 69 (2009) 2956. — 24. BRESLOW NE, DAY NE, Statistical
Methods in Cancer Research. Vol. II. The analysis of case-control studies.
IARC Scientific Publications No. 32. (International Agency for Research
on Cancer, Lyon, 1980). — 25. WHO REGIONAL OFFICE FOR EUROPE.
European Health for All database (HFA-DB), ACCESSED 01.07.2009.
Available from: URL: http://www.euro.who.int/hfadb. — 26. KOVA^I] L,
GAZDEK D, SAMARD@I] S, Acta Med Croatica, 61 (2007) 281. — 27. To-
bacco product use restriction act [In Croatian], Narodne novine 125 (2008).
— 28. MILO[EVI] M, MUSTAJBEGOVI] J, ABDOVI] S, [ULENTI] P,
PUCARIN-CVETKOVI] J, Acta Med Croatica, 61 (2007) 275. — 29. IN-
TERNATIONAL AGENCY FOR RESEARCH ON CANCER, Fruit and Ve-
getables. IARC Handbooks of Cancer Prevention Vol. 8 (International
Agency for Research on Cancer, Lyon, 2003). — 30. SAPKOTA A, HSU CC,
ZARIDZE D, SHANGINA O, SZESZENIA-DABROWSKAN, MATES D, FA-
BIANOV E, RUDNAI P, JANOUT V, HOLCATOVA I, BRENNAN P, BOF-
FETTA P, HASHIBE M, Cancer Causes Control, 19 (2008) 1161. — 31.
KAI]-RAK A, PUCARIN-CVETKOVI] J, KULIER I, Acta Med Croatica,
61 (2007) 259. — 32. HASHIBE M, MCKAY JD, CURADO MP, OLIVIERA
JC, KOIFMAN S, KOIFMAN R, ZARIDZE D, SHANGINA O, WÜNSCH-
-FILHO V, ELUF-NETO J, LEVI JE, MATOS E, LAGIOU P, LAGIOU A,
BENHAMOU S, BOUCHARDY C, SZESZENIA-DABROWSKA N, MENE-
ZES A, DALL’AGNOL MM, MERLETTI F, RICHIARDI L, FERNANDEZ
L, LENCE J, TALAMINI R, BARZAN L, MATES D, MATES IN, KJAE-
RHEIM K, MACFARLANE GJ, MACFARLANE TV, SIMONATO L, CA-
NOVA C, HOLCATOVA I, AGUDO A, CASTELLSAGUE X, LOWRY R, JA-
NOUT V, KOLLAROVA H, CONWAY DI, MCKINNEY PA, ZNAOR A,
FABIANOVA E, BENCKO V, LISSOWSKA J, CHABRIER A, HUNG RJ,
GABORIEAU V, BOFFETTA P, BRENNAN P, Nat Genet, 40 (2008) 707.
A. Znaor
Croatian National Institute of Public Health, Croatian National Cancer Registry, Rockefellerova 7,
10000 Zagreb, Croatia
e-mail: ariana.znaor@hzjz.hr
@IVOTNE NAVIKE I RIZIK ZA RAK GLAVE I VRATA U ZAGREBA^KOJ REGIJI
S A @ E T A K
Me|unarodna agencija za istra`ivanje raka 2002. godine zapo~ela je multicentri~no slu~aj-kontrola istra`ivanje raka
glave i vrata u 15 cenara u 11 europskih dr`ava uklju~uju}i Hrvatsku. Baza podataka istra`ivanja ARCAGE s oko 2500
parova slu~aj-kontrola trenutno je najve}a baza podataka o bolesnicima od raka glave i vrata u Europi. Cilj ovog istra-
`ivanja bio je procijeniti rizik pu{enja i konzumacije alkohola u bolesnika od raka glave i vrata iz zagreba~ke regije
regrutiranih u okviru istra`ivanja ARCAGE. Slu~ajevi (45 mu{karaca i 9 `ena) i kontrole (37 mu{karaca, 9 `ena) regru-
tirani su iz Klin~ke bolnice Dubrava i Klini~ke bolnice Merkur. Od svih ispitanika prikupljen je uzorak krvi i anketni
upitnik. Podaci su analizirani logisti~kom regresijom. Raspodjela slu~ajeva bila je: 43 slu~aja raka usne {upljine, 9
`drijela i 2 grkljana. Pu{a~i su imali ~etverostruko ve}i rizik za rak glave i vrata od nepu{a~a (OR 4,3 (CI 1,20–15,4)).
Prilago|eni odnos {ansi za konzumaciju alkohola vi{e od jednom tjedno bio je 4,1 (CI 1,5–11,2). Rezultati su u skladu s
prethodno objavljenim podacima iz drugih zemalja.
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